World's Best Scientists 2026 revealed!
Jerald C. Sadoff

Jerald C. Sadoff

Award Badge
Immunology
Belgium
2026

D-Index & Metrics

Immunology

D-Index
92
Citations
34323
World Ranking
1001
National Ranking
8

Medicine

D-Index
92
Citations
34344
World Ranking
11226
National Ranking
135

Research.com Recognitions

  • 2026 - Research.com Immunology in Belgium Leader Award
  • 2025 - Research.com Immunology in Belgium Leader Award

Overview

Jerald C. Sadoff is affiliated with Janssen in Belgium and has an extensive research profile primarily in the field of Medicine. Their work focuses significantly on Infectious Diseases, with notable contributions to Epidemiology, Immunology, Molecular Biology, and Genetics as subfields of study.

The main topics central to their research include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Respiratory viral infections research
  • Vaccines and immunoinformatics approaches
  • Virus-based gene therapy research
  • Influenza Virus Research Studies
  • Vaccine Coverage and Hesitancy

Jerald C. Sadoff has contributed to several peer-reviewed journals and publication venues, frequently appearing in the following:

  • New England Journal of Medicine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Vaccine
  • Open Forum Infectious Diseases
  • UNC Libraries

Some of their recent papers include:

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19, 2021, New England Journal of Medicine
  • Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine, 2021, New England Journal of Medicine
  • Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans, 2021, Nature
  • Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19, 2021, JAMA
  • Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination, 2021, New England Journal of Medicine

In terms of collaboration, Jerald C. Sadoff frequently co-authors with several researchers including:

  • Mathieu Le Gars
  • Macaya Douoguih
  • Hanneke Schuitemaker
  • Frank Struyf
  • Carla Truyers

Best Publications

  • Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.

    Jerald Sadoff;Glenda Gray;An Vandebosch;Vicky Cárdenas

  • Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

    Ziegler Ej;Fisher Cj;Sprung Cl;Straube Rc

  • Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein

    Charles J. Fisher;Jan M. Agosti;Steven M. Opal;Stephen F. Lowry

  • Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

    Fisher Cj;Dhainaut Jf;Opal Sm;Pribble Jp

  • Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a Mutant Escherichia coli

    Ziegler Ej;McCutchan Ja;Fierer J;Glauser Mp

  • Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.

    Jerald Sadoff;Mathieu Le Gars;Georgi Shukarev;Dirk Heerwegh

  • Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

    Steven M. Opal;Charles J. Fisher;Jean-Francois A. Dhainaut;Jean-Louis Vincent

  • Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis

    Charles J. Fisher;S.M. Opal;Jean-Francois Dhainaut;S Stephens

  • Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys

    Dan H. Barouch;Dan H. Barouch;Jinyan Liu;Hualin Li;Lori F. Maxfield

  • Attenuated Shigella as a DNA Delivery Vehicle for DNA-Mediated Immunization

    Donata R. Sizemore;Arthur A. Branstrom;Jerald C. Sadoff

  • Advances in tuberculosis vaccine strategies.

    Yasir A. W. Skeiky;Jerald C. Sadoff

  • Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine.

    D. M. Gordon;T. W. McGovern;U. Krzych;J. C. Cohen

  • Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria.

    JC Sadoff;WR Ballou;LS Baron;WR Majarian

  • Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

    Unknown

  • Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

    Dan H Barouch;Dan H Barouch;Frank L Tomaka;Frank Wegmann;Daniel J Stieh

  • Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.

    Terhi Kilpi;Heidi Åhman;Jukka Jokinen;Kari S. Lankinen

  • Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults

    Dani Cohen;Dani Cohen;Shai Ashkenazi;Shai Ashkenazi;Manfred S Green;Manfred S Green;Michael Gdalevich

  • The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat.

    Kwang Sik Kim;Hideo Itabashi;Peter Gemski;Jerald Sadoff

  • Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.

    A S Cross;J C Sadoff;N Kelly;E Bernton

  • Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC-Pf7, a Pox-Vectored, Multiantigen, Multistage Vaccine Candidate for Plasmodium falciparum Malaria

    Christian F. Ockenhouse;Pei Fang Sun;David E. Lanar;Bruce T. Wellde

  • Use of Azithromycin for the Treatment of Campylobacter Enteritis in Travelers to Thailand, an Area Where Ciprofloxacin Resistance Is Prevalent

    Robert A. Kuschner;Andrew F. Trofa;Richard J. Thomas;Charles W. Hoge

  • Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans.

    Galit Alter;Galit Alter;Jingyou Yu;Jinyan Liu;Abishek Chandrashekar

Frequent Co-Authors

Alan S. Cross
Alan S. Cross University of Maryland, Baltimore
Stanley J. Cryz
Stanley J. Cryz University of Massachusetts Chan Medical School
David N. Taylor
David N. Taylor Johns Hopkins University
Steven M. Opal
Steven M. Opal Brown University
Barbara H. Iglewski
Barbara H. Iglewski University of Rochester
Dan H. Barouch
Dan H. Barouch Harvard Medical School
Hanneke Schuitemaker
Hanneke Schuitemaker Valneva (Austria)
Willem A. Hanekom
Willem A. Hanekom University College London
Jaap Goudsmit
Jaap Goudsmit Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Programs like Licensed Practical Nurse (LPN) paths often serve as entry points into the medical field, and those looking for less stringent admissions may find the lpn programs with easiest admission requirements particularly appealing. These programs provide foundational patient care skills that complement immunological knowledge.

Advancing further, many pursue Nurse Practitioner degrees that combine clinical expertise with specialized practice. The easiest nurse practitioner program options can help professionals transition smoothly, balancing coursework and practical experience.

Specialties such as psychiatric mental health nurse practitioner (PMHNP) programs integrate immunological studies with mental health, often featuring robust clinical placement opportunities. Interested students should consider the best pmhnp programs to maximize hands-on experience and career readiness.

Cost is also crucial when selecting a program. Fortunately, several affordable options exist, and exploring the cheapest psych np programs can reduce financial barriers while ensuring quality education in psychiatric nursing aligned with immunological principles.

Best Scientists Citing Jerald C. Sadoff

Trending Scientists

Recently Published Articles